Afya (NASDAQ:AFYA) Downgraded by Morgan Stanley to “Underweight”

Afya (NASDAQ:AFYA) was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating in a research report issued to clients and investors on Tuesday,Briefing.com Automated Import reports. They currently have a $17.00 price objective on the stock, down from their previous price objective of $19.00. Morgan Stanley’s price target suggests a potential upside of 0.18% from the stock’s current price.

Several other research analysts have also commented on AFYA. The Goldman Sachs Group initiated coverage on shares of Afya in a research note on Tuesday, December 3rd. They set a “sell” rating and a $16.00 price objective for the company. JPMorgan Chase & Co. cut their price target on shares of Afya from $25.00 to $20.50 and set a “neutral” rating on the stock in a research note on Friday, January 17th. Finally, Citigroup restated a “sell” rating and set a $15.00 price target (down previously from $18.00) on shares of Afya in a research note on Friday, January 31st. Three research analysts have rated the stock with a sell rating and two have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus price target of $17.60.

Afya Trading Down 0.9 %

NASDAQ AFYA opened at $16.97 on Tuesday. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.51. The firm has a market cap of $1.59 billion, a PE ratio of 13.69, a price-to-earnings-growth ratio of 0.29 and a beta of 0.82. The company has a 50 day moving average price of $16.35 and a 200 day moving average price of $16.47. Afya has a 52 week low of $14.52 and a 52 week high of $22.24.

Institutional Trading of Afya

A number of hedge funds and other institutional investors have recently made changes to their positions in AFYA. Quantbot Technologies LP increased its stake in shares of Afya by 73.8% in the third quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock worth $226,000 after acquiring an additional 5,636 shares during the period. PDT Partners LLC acquired a new stake in shares of Afya in the third quarter worth $481,000. Erste Asset Management GmbH purchased a new stake in Afya during the third quarter worth $822,000. Centiva Capital LP purchased a new stake in Afya during the third quarter worth $213,000. Finally, Point72 Asset Management L.P. purchased a new stake in Afya during the third quarter worth $842,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.